Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors.
Pedersen-Bjergaard
J
J
Laboratory for Cancer Genetics and Cytogenetics, the Finsen Center, Rigshospitalet, the University Hospital of Copenhagen, Denmark.
Andersen
M K
MK
Johansson
B
B
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002869:Chromosome Aberrations; D015321:Gene Rearrangement; D006801:Humans; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000235:genetics*; D059005:Topoisomerase II Inhibitors; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D059005:Topoisomerase II Inhibitors